Skip to main content
Floor vote

Senate vote #103

On the Amendment S.Amdt. 5336 to S.Con.Res. 33 (No short title on file)

To establish a deficit-neutral reserve fund relating to requiring the Comptroller General of the United States to conduct a study related to economic consequences of private or confidential drug pricing agreements struck by any Federal department, agency, or office with … Read full descriptionHide

To establish a deficit-neutral reserve fund relating to requiring the Comptroller General of the United States to conduct a study related to economic consequences of private or confidential drug pricing agreements struck by any Federal department, agency, or office with any pharmaceutical manufacturer.

Rejected Congress 119 · Session 2 Apr 23, 2026 · 2:51 AM EDT  SCONRES 33
REJECTED
48–50
+2 margin
Democrats
44
Republicans
2 50
Independents
2
Majority threshold YES 48 50 NO
98 members voted · 2 Not Voting Failed by 2 votes
Crossed the aisle 2

Members who voted against their own party's majority position.

Republican Voted NAY (50 against, 2 for), but 2 members below broke ranks and voted YEA.
Present or didn't vote
Report a problem